Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT05240235
Eligibility Criteria:
Inclusion Criteria:
1. Patients who underwent breast-conserving surgery and received adjuvant radiotherapy
2. Patients with Sentinel Lymph Node Biopsy or axillary lymph node dissection
3. Female patients between the ages of 18-75
4. Patients who cannot read and write Turkish
Exclusion Criteria:
1. A previous cancer
2. Decompensated heart failure
3. Untreated congestive heart failure
4. Active infection
5. Uncontrolled hypertension
6. Acute kidney failure
7. Patients with acute deep vein thrombosis
8. Metastasis and/or recurrence during treatment
9. Patients who have undergone another surgery related to the breast and chest area
10. Patients who develop lymphedema in the upper extremity during therapy will be excluded from the study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05240235
Study Brief:
Protocol Section:
NCT05240235